Isturisa (osilodrostat tablets – Recordati Rare Diseases) — Cigna
Endogenous Cushing’s Syndrome (including Cushing’s disease)
Initial criteria
- Patient age ≥ 18 years; AND
- According to the prescriber, the patient is not a candidate for surgery or surgery has not been curative; OR patient is awaiting surgery for endogenous Cushing’s syndrome; OR patient is awaiting therapeutic response after radiotherapy for endogenous Cushing’s syndrome; AND
- Medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of endogenous Cushing’s syndrome
Approval duration
1 year